Prescription Dermatology Therapeutics Market value is projected to reach US$ 72.27 Bn at the end of the forecast period and it is expected to grow at the CAGR of 9.5%.Prescription Dermatology Therapeutics Market Drivers and Restrains:
The prescription dermatology therapeutics market witnessed a significant growth rate owing to high incidence and an increase in the prevalence rate of infectious and chronic dermatological disorders, and novel drug development across the world. Skin is the largest and most exposed organ body part to a wide variety of toxins and microbes. Lengthy exposure of skin to toxins effects in various kinds of skin disorders. Skin disease is one of the leading causes of non-fatal disease burden globally, affecting millions of people.To know about the Research Methodology :- Request Free Sample Report Aging, trauma, and environmental and genetic factors can result in the development of skin diseases, which are impelling the demand for dermatology treatment worldwide. Study of the World Health Organization (WHO), skin diseases are among the most common human health disorders and affect almost xx million people across the world. Some of the most common types of skin diseases reported worldwide are pyoderma, scabies, acne, eczema, and warts.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Acne treatment drugs are the most common type of prescription drugs, which are used to improve the skin’s texture and color. According to the American Academy of Dermatology, acne is the most prevalent skin condition, which affects almost xx million Americans yearly. Dermatology drugs used to treat baldness are also very common. Hair loss can be caused by various factors, such as hormonal causes, stress, chemotherapy, radiation, etc. High prevalence and rise in incidence rates of chronic dermatological disorders with significant unmet medical needs are driving the market growth. However stringent regulations for approval of dermatology drugs are restraining the market growth at global level. The key manufacturers to move their focus towards the dermatological segment which leads them to provide good business opportunities in prescription dermatology therapeutics market.
Prescription Dermatology Therapeutics Market Segment Analysis:
Based on the distribution channels, the prescription dermatology therapeutics market has been segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. The hospital pharmacies segment dominated the prescription dermatology therapeutics market in 2022 and is likely to continue this trend during the forecast period. Long-term management of chronic dermatological disorders, increase in rate of hospitalization, and availability of high cost biologic drugs are anticipated to witness a significant segment growth during the forecast period.Prescription Dermatology Therapeutics Market Regional Insights:
Geographically, the prescription dermatology therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest market share of xx% in 2022. High prevalence of chronic skin disorders, increase in adoption of biologic drugs for the treatment of moderate to severe plaque psoriasis, and anticipated new product approvals are expected to drive the growth of the prescription dermatology therapeutics market in North America. The market in Asia Pacific is expected to expand at a high CAGR of xx% during the forecast period. Increase in awareness about various skin disorders, rapidly changing health care infrastructure, rise in access to skin care treatments in the developing countries such as China and India. Well-established pharmaceutical market in Japan, and surge in adoption of biologic drugs in Australia and New Zealand are anticipated to impel the market growth in Asia Pacific during the forecast period. A report covers the recent development for market in the prescription dermatology therapeutics market like, Aurobindo Pharma had nearby 38 products under development in dermatology therapeutics in topical forms. The company has around 24 products in the portfolio that requires clinical trials.Prescription Dermatology Therapeutics Market Competitive landscape
Major Key players operating in this market are AbbVie, Inc., Janssen Biotech, Inc., Novartis AG, Amgen, Inc., Celgene Corporation, Pfizer, Inc. Manufacturers in the prescription dermatology therapeutics are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers. The objective of the report is to present comprehensive analysis of prescription dermatology therapeutics market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding prescription dermatology therapeutics market dynamics, structure by analyzing the market segments, and project the prescription dermatology therapeutics market size. Clear representation of competitive analysis of key players by product type, price, financial position, product portfolio, growth strategies, and regional presence in the prescription dermatology therapeutics market make the report investor’s guide.Prescription Dermatology Therapeutics Market Scope: Inquire before buying
Global Prescription Dermatology Therapeutics Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 38.28 Bn. Forecast Period 2023 to 2029 CAGR: 9.5% Market Size in 2029: US $ 72.27 Bn. Segments Covered: by Product • Acne and Rosacea Drugs • Fungal Infection Drugs • Psoriasis Drugs • Hyperpigmentation/ Melisma Drugs • Skin Cancer Drugs • Hair Loss and Hair Removal Drugs • Antiaging and Photo Damage Drugs • Dermatitis and Seborrhea Drugs by Distribution Channel • Hospital Pharmacies • Retail pharmacies • Mail order pharmacies Prescription Dermatology Therapeutics Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Prescription Dermatology Therapeutics Market, Key Players are:
• AbbVie, Inc. • Janssen Biotech, Inc. • Novartis AG, • Amgen, Inc. • Celgene Corporation • Pfizer, Inc. • LEO Pharma A/S • Eli Lilly and Company • Bausch Health Companies, Inc. • Sun Pharmaceuticals Ltd. • Aclaris Therapeutics, Inc. • Aurobindo Pharma Ltd. • Allergan Inc. • Bayer AG • Bristol-Myers Squibb Company • F. Hoffmann-La Roche Ltd. • Genentech, Inc. • GlaxoSmithKline Plc • Merck & Company, Inc. • SkinMedica • Stiefel Laboratories, Inc. • Valeant Pharmaceuticals, Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Prescription Dermatology Therapeutics Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Prescription Dermatology Therapeutics Market? Ans: The Global Prescription Dermatology Therapeutics Market is growing at a CAGR of 9.5% during forecasting period 2023-2029. 3. What is scope of the Global Prescription Dermatology Therapeutics market report? Ans: Global Prescription Dermatology Therapeutics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Prescription Dermatology Therapeutics market? Ans: The important key players in the Global Prescription Dermatology Therapeutics Market are – AbbVie, Inc., Janssen Biotech, Inc., Novartis AG, Amgen, Inc., Celgene Corporation, Pfizer, Inc., LEO Pharma A/S, Eli Lilly and Company, Bausch Health Companies, Inc., Sun Pharmaceuticals Ltd., Aclaris Therapeutics, Inc., Aurobindo Pharma Ltd., Allergan Inc., Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline Plc, Merck & Company, and Inc. 5. What is the study period of this market? Ans: The Global Prescription Dermatology Therapeutics Market is studied from 2022 to 2029.
Prescription Dermatology Therapeutics Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Prescription Dermatology Therapeutics Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Prescription Dermatology Therapeutics Market Analysis and Forecast 6.1. Global Prescription Dermatology Therapeutics Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Prescription Dermatology Therapeutics Market Analysis and Forecast, by Product Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Prescription Dermatology Therapeutics Market Value Share Analysis, by Product Type 7.4. Global Prescription Dermatology Therapeutics Market Size (US$ Bn) Forecast, by Product Type 7.5. Global Prescription Dermatology Therapeutics Market Analysis, by Product Type 7.6. Global Prescription Dermatology Therapeutics Market Attractiveness Analysis, by Product Type 8. Global Prescription Dermatology Therapeutics Market Analysis and Forecast, by Distribution Channel 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Prescription Dermatology Therapeutics Market Value Share Analysis, by Distribution Channel 8.4. Global Prescription Dermatology Therapeutics Market Size (US$ Bn) Forecast, by Distribution Channel 8.5. Global Prescription Dermatology Therapeutics Market Analysis, by Distribution Channel 8.6. Global Prescription Dermatology Therapeutics Market Attractiveness Analysis, by Distribution Channel 9. Global Prescription Dermatology Therapeutics Market Analysis, by Region 9.1. Global Prescription Dermatology Therapeutics Market Value Share Analysis, by Region 9.2. Global Prescription Dermatology Therapeutics Market Size (US$ Bn) Forecast, by Region 9.3. Global Prescription Dermatology Therapeutics Market Attractiveness Analysis, by Region 10. North America Prescription Dermatology Therapeutics Market Analysis 10.1. Key Findings 10.2. North America Prescription Dermatology Therapeutics Market Overview 10.3. North America Prescription Dermatology Therapeutics Market Value Share Analysis, by Product Type 10.4. North America Prescription Dermatology Therapeutics Market Forecast, by Product Type 10.4.1. Acne and Rosacea Drugs 10.4.2. Fungal Infection Drugs 10.4.3. Psoriasis Drugs 10.4.4. Hyperpigmentation/ Melisma Drugs 10.4.5. Skin Cancer Drugs 10.4.6. Hair Loss and Hair Removal Drugs 10.4.7. Antiaging and Photo Damage Drugs 10.4.8. Dermatitis and Seborrhea Drugs 10.5. North America Prescription Dermatology Therapeutics Market Value Share Analysis, by Distribution Channel 10.6. North America Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 10.6.1. Hospital Pharmacies 10.6.2. Retail pharmacies 10.6.3. Mail order pharmacies 10.7. North America Prescription Dermatology Therapeutics Market Value Share Analysis, by Country 10.8. North America Prescription Dermatology Therapeutics Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Prescription Dermatology Therapeutics Market Analysis, by Country 10.10. U.S. Prescription Dermatology Therapeutics Market Forecast, by Product Type 10.10.1. Acne and Rosacea Drugs 10.10.2. Fungal Infection Drugs 10.10.3. Psoriasis Drugs 10.10.4. Hyperpigmentation/ Melisma Drugs 10.10.5. Skin Cancer Drugs 10.10.6. Hair Loss and Hair Removal Drugs 10.10.7. Antiaging and Photo Damage Drugs 10.10.8. Dermatitis and Seborrhea Drugs 10.11. U.S. Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 10.11.1. Hospital Pharmacies 10.11.2. Retail pharmacies 10.11.3. Mail order pharmacies 10.12. Canada Prescription Dermatology Therapeutics Market Forecast, by Product Type 10.12.1. Acne and Rosacea Drugs 10.12.2. Fungal Infection Drugs 10.12.3. Psoriasis Drugs 10.12.4. Hyperpigmentation/ Melisma Drugs 10.12.5. Skin Cancer Drugs 10.12.6. Hair Loss and Hair Removal Drugs 10.12.7. Antiaging and Photo Damage Drugs 10.12.8. Dermatitis and Seborrhea Drugs 10.13. Canada Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 10.13.1. Hospital Pharmacies 10.13.2. Retail pharmacies 10.13.3. Mail order pharmacies 10.14. North America Prescription Dermatology Therapeutics Market Attractiveness Analysis 10.14.1. By Product Type 10.14.2. By Distribution Channel 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Prescription Dermatology Therapeutics Market Analysis 11.1. Key Findings 11.2. Europe Prescription Dermatology Therapeutics Market Overview 11.3. Europe Prescription Dermatology Therapeutics Market Value Share Analysis, by Product Type 11.4. Europe Prescription Dermatology Therapeutics Market Forecast, by Product Type 11.4.1. Acne and Rosacea Drugs 11.4.2. Fungal Infection Drugs 11.4.3. Psoriasis Drugs 11.4.4. Hyperpigmentation/ Melisma Drugs 11.4.5. Skin Cancer Drugs 11.4.6. Hair Loss and Hair Removal Drugs 11.4.7. Antiaging and Photo Damage Drugs 11.4.8. Dermatitis and Seborrhea Drugs 11.5. Europe Prescription Dermatology Therapeutics Market Value Share Analysis, by Distribution Channel 11.6. Europe Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 11.6.1. Hospital Pharmacies 11.6.2. Retail pharmacies 11.6.3. Mail order pharmacies 11.7. Europe Prescription Dermatology Therapeutics Market Value Share Analysis, by Country 11.8. Europe Prescription Dermatology Therapeutics Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Prescription Dermatology Therapeutics Market Analysis, by Country 11.10. Germany Prescription Dermatology Therapeutics Market Forecast, by Product Type 11.10.1. Acne and Rosacea Drugs 11.10.2. Fungal Infection Drugs 11.10.3. Psoriasis Drugs 11.10.4. Hyperpigmentation/ Melisma Drugs 11.10.5. Skin Cancer Drugs 11.10.6. Hair Loss and Hair Removal Drugs 11.10.7. Antiaging and Photo Damage Drugs 11.10.8. Dermatitis and Seborrhea Drugs 11.11. Germany Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 11.11.1. Hospital Pharmacies 11.11.2. Retail pharmacies 11.11.3. Mail order pharmacies 11.12. U.K. Prescription Dermatology Therapeutics Market Forecast, by Product Type 11.12.1. Acne and Rosacea Drugs 11.12.2. Fungal Infection Drugs 11.12.3. Psoriasis Drugs 11.12.4. Hyperpigmentation/ Melisma Drugs 11.12.5. Skin Cancer Drugs 11.12.6. Hair Loss and Hair Removal Drugs 11.12.7. Antiaging and Photo Damage Drugs 11.12.8. Dermatitis and Seborrhea Drugs 11.13. U.K. Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 11.13.1. Hospital Pharmacies 11.13.2. Retail pharmacies 11.13.3. Mail order pharmacies 11.14. France Prescription Dermatology Therapeutics Market Forecast, by Product Type 11.14.1. Acne and Rosacea Drugs 11.14.2. Fungal Infection Drugs 11.14.3. Psoriasis Drugs 11.14.4. Hyperpigmentation/ Melisma Drugs 11.14.5. Skin Cancer Drugs 11.14.6. Hair Loss and Hair Removal Drugs 11.14.7. Antiaging and Photo Damage Drugs 11.14.8. Dermatitis and Seborrhea Drugs 11.15. France Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 11.15.1. Hospital Pharmacies 11.15.2. Retail pharmacies 11.15.3. Mail order pharmacies 11.16. Italy Prescription Dermatology Therapeutics Market Forecast, by Product Type 11.16.1. Acne and Rosacea Drugs 11.16.2. Fungal Infection Drugs 11.16.3. Psoriasis Drugs 11.16.4. Hyperpigmentation/ Melisma Drugs 11.16.5. Skin Cancer Drugs 11.16.6. Hair Loss and Hair Removal Drugs 11.16.7. Antiaging and Photo Damage Drugs 11.16.8. Dermatitis and Seborrhea Drugs 11.17. Italy Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 11.17.1. Hospital Pharmacies 11.17.2. Retail pharmacies 11.17.3. Mail order pharmacies 11.18. Spain Prescription Dermatology Therapeutics Market Forecast, by Product Type 11.18.1. Acne and Rosacea Drugs 11.18.2. Fungal Infection Drugs 11.18.3. Psoriasis Drugs 11.18.4. Hyperpigmentation/ Melisma Drugs 11.18.5. Skin Cancer Drugs 11.18.6. Hair Loss and Hair Removal Drugs 11.18.7. Antiaging and Photo Damage Drugs 11.18.8. Dermatitis and Seborrhea Drugs 11.19. Spain Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 11.19.1. Hospital Pharmacies 11.19.2. Retail pharmacies 11.19.3. Mail order pharmacies 11.20. Rest of Europe Prescription Dermatology Therapeutics Market Forecast, by Product Type 11.20.1. Acne and Rosacea Drugs 11.20.2. Fungal Infection Drugs 11.20.3. Psoriasis Drugs 11.20.4. Hyperpigmentation/ Melisma Drugs 11.20.5. Skin Cancer Drugs 11.20.6. Hair Loss and Hair Removal Drugs 11.20.7. Antiaging and Photo Damage Drugs 11.20.8. Dermatitis and Seborrhea Drugs 11.21. Rest of Europe Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 11.21.1. Hospital Pharmacies 11.21.2. Retail pharmacies 11.21.3. Mail order pharmacies 11.22. Europe Prescription Dermatology Therapeutics Market Attractiveness Analysis 11.22.1. By Product Type 11.22.2. By Distribution Channel 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Prescription Dermatology Therapeutics Market Analysis 12.1. Key Findings 12.2. Asia Pacific Prescription Dermatology Therapeutics Market Overview 12.3. Asia Pacific Prescription Dermatology Therapeutics Market Value Share Analysis, by Product Type 12.4. Asia Pacific Prescription Dermatology Therapeutics Market Forecast, by Product Type 12.4.1. Acne and Rosacea Drugs 12.4.2. Fungal Infection Drugs 12.4.3. Psoriasis Drugs 12.4.4. Hyperpigmentation/ Melisma Drugs 12.4.5. Skin Cancer Drugs 12.4.6. Hair Loss and Hair Removal Drugs 12.4.7. Antiaging and Photo Damage Drugs 12.4.8. Dermatitis and Seborrhea Drugs 12.5. Asia Pacific Prescription Dermatology Therapeutics Market Value Share Analysis, by Distribution Channel 12.6. Asia Pacific Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 12.6.1. Hospital Pharmacies 12.6.2. Retail pharmacies 12.6.3. Mail order pharmacies 12.7. Asia Pacific Prescription Dermatology Therapeutics Market Value Share Analysis, by Country 12.8. Asia Pacific Prescription Dermatology Therapeutics Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Prescription Dermatology Therapeutics Market Analysis, by Country 12.10. China Prescription Dermatology Therapeutics Market Forecast, by Product Type 12.10.1. Acne and Rosacea Drugs 12.10.2. Fungal Infection Drugs 12.10.3. Psoriasis Drugs 12.10.4. Hyperpigmentation/ Melisma Drugs 12.10.5. Skin Cancer Drugs 12.10.6. Hair Loss and Hair Removal Drugs 12.10.7. Antiaging and Photo Damage Drugs 12.10.8. Dermatitis and Seborrhea Drugs 12.11. China Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 12.11.1. Hospital Pharmacies 12.11.2. Retail pharmacies 12.11.3. Mail order pharmacies 12.12. India Prescription Dermatology Therapeutics Market Forecast, by Product Type 12.12.1. Acne and Rosacea Drugs 12.12.2. Fungal Infection Drugs 12.12.3. Psoriasis Drugs 12.12.4. Hyperpigmentation/ Melisma Drugs 12.12.5. Skin Cancer Drugs 12.12.6. Hair Loss and Hair Removal Drugs 12.12.7. Antiaging and Photo Damage Drugs 12.12.8. Dermatitis and Seborrhea Drugs 12.13. India Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 12.13.1. Hospital Pharmacies 12.13.2. Retail pharmacies 12.13.3. Mail order pharmacies 12.14. Japan Prescription Dermatology Therapeutics Market Forecast, by Product Type 12.14.1. Acne and Rosacea Drugs 12.14.2. Fungal Infection Drugs 12.14.3. Psoriasis Drugs 12.14.4. Hyperpigmentation/ Melisma Drugs 12.14.5. Skin Cancer Drugs 12.14.6. Hair Loss and Hair Removal Drugs 12.14.7. Antiaging and Photo Damage Drugs 12.14.8. Dermatitis and Seborrhea Drugs 12.15. Japan Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 12.15.1. Hospital Pharmacies 12.15.2. Retail pharmacies 12.15.3. Mail order pharmacies 12.16. ASEAN Prescription Dermatology Therapeutics Market Forecast, by Product Type 12.16.1. Acne and Rosacea Drugs 12.16.2. Fungal Infection Drugs 12.16.3. Psoriasis Drugs 12.16.4. Hyperpigmentation/ Melisma Drugs 12.16.5. Skin Cancer Drugs 12.16.6. Hair Loss and Hair Removal Drugs 12.16.7. Antiaging and Photo Damage Drugs 12.16.8. Dermatitis and Seborrhea Drugs 12.17. ASEAN Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 12.17.1. Hospital Pharmacies 12.17.2. Retail pharmacies 12.17.3. Mail order pharmacies 12.18. Rest of Asia Pacific Prescription Dermatology Therapeutics Market Forecast, by Product Type 12.18.1. Acne and Rosacea Drugs 12.18.2. Fungal Infection Drugs 12.18.3. Psoriasis Drugs 12.18.4. Hyperpigmentation/ Melisma Drugs 12.18.5. Skin Cancer Drugs 12.18.6. Hair Loss and Hair Removal Drugs 12.18.7. Antiaging and Photo Damage Drugs 12.18.8. Dermatitis and Seborrhea Drugs 12.19. Rest of Asia Pacific Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 12.19.1. Hospital Pharmacies 12.19.2. Retail pharmacies 12.19.3. Mail order pharmacies 12.20. Asia Pacific Prescription Dermatology Therapeutics Market Attractiveness Analysis 12.20.1. By Product Type 12.20.2. By Distribution Channel 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Prescription Dermatology Therapeutics Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Prescription Dermatology Therapeutics Market Overview 13.3. Middle East & Africa Prescription Dermatology Therapeutics Market Value Share Analysis, by Product Type 13.4. Middle East & Africa Prescription Dermatology Therapeutics Market Forecast, by Product Type 13.4.1. Acne and Rosacea Drugs 13.4.2. Fungal Infection Drugs 13.4.3. Psoriasis Drugs 13.4.4. Hyperpigmentation/ Melisma Drugs 13.4.5. Skin Cancer Drugs 13.4.6. Hair Loss and Hair Removal Drugs 13.4.7. Antiaging and Photo Damage Drugs 13.4.8. Dermatitis and Seborrhea Drugs 13.5. Middle East & Africa Prescription Dermatology Therapeutics Market Value Share Analysis, by Distribution Channel 13.6. Middle East & Africa Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 13.6.1. Hospital Pharmacies 13.6.2. Retail pharmacies 13.6.3. Mail order pharmacies 13.7. Middle East & Africa Prescription Dermatology Therapeutics Market Value Share Analysis, by Country 13.8. Middle East & Africa Prescription Dermatology Therapeutics Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Prescription Dermatology Therapeutics Market Analysis, by Country 13.10. GCC Prescription Dermatology Therapeutics Market Forecast, by Product Type 13.10.1. Acne and Rosacea Drugs 13.10.2. Fungal Infection Drugs 13.10.3. Psoriasis Drugs 13.10.4. Hyperpigmentation/ Melisma Drugs 13.10.5. Skin Cancer Drugs 13.10.6. Hair Loss and Hair Removal Drugs 13.10.7. Antiaging and Photo Damage Drugs 13.10.8. Dermatitis and Seborrhea Drugs 13.11. GCC Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 13.11.1. Hospital Pharmacies 13.11.2. Retail pharmacies 13.11.3. Mail order pharmacies 13.12. South Africa Prescription Dermatology Therapeutics Market Forecast, by Product Type 13.12.1. Acne and Rosacea Drugs 13.12.2. Fungal Infection Drugs 13.12.3. Psoriasis Drugs 13.12.4. Hyperpigmentation/ Melisma Drugs 13.12.5. Skin Cancer Drugs 13.12.6. Hair Loss and Hair Removal Drugs 13.12.7. Antiaging and Photo Damage Drugs 13.12.8. Dermatitis and Seborrhea Drugs 13.13. South Africa Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 13.13.1. Hospital Pharmacies 13.13.2. Retail pharmacies 13.13.3. Mail order pharmacies 13.14. Rest of Middle East & Africa Prescription Dermatology Therapeutics Market Forecast, by Product Type 13.14.1. Acne and Rosacea Drugs 13.14.2. Fungal Infection Drugs 13.14.3. Psoriasis Drugs 13.14.4. Hyperpigmentation/ Melisma Drugs 13.14.5. Skin Cancer Drugs 13.14.6. Hair Loss and Hair Removal Drugs 13.14.7. Antiaging and Photo Damage Drugs 13.14.8. Dermatitis and Seborrhea Drugs 13.15. Rest of Middle East & Africa Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 13.15.1. Hospital Pharmacies 13.15.2. Retail pharmacies 13.15.3. Mail order pharmacies 13.16. Middle East & Africa Prescription Dermatology Therapeutics Market Attractiveness Analysis 13.16.1. By Product Type 13.16.2. By Distribution Channel 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Prescription Dermatology Therapeutics Market Analysis 14.1. Key Findings 14.2. South America Prescription Dermatology Therapeutics Market Overview 14.3. South America Prescription Dermatology Therapeutics Market Value Share Analysis, by Product Type 14.4. South America Prescription Dermatology Therapeutics Market Forecast, by Product Type 14.4.1. Acne and Rosacea Drugs 14.4.2. Fungal Infection Drugs 14.4.3. Psoriasis Drugs 14.4.4. Hyperpigmentation/ Melisma Drugs 14.4.5. Skin Cancer Drugs 14.4.6. Hair Loss and Hair Removal Drugs 14.4.7. Antiaging and Photo Damage Drugs 14.4.8. Dermatitis and Seborrhea Drugs 14.5. Others South America Prescription Dermatology Therapeutics Market Value Share Analysis, by Distribution Channel 14.6. South America Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 14.6.1. Hospital Pharmacies 14.6.2. Retail pharmacies 14.6.3. Mail order pharmacies 14.7. South America Prescription Dermatology Therapeutics Market Value Share Analysis, by Country 14.8. South America Prescription Dermatology Therapeutics Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Prescription Dermatology Therapeutics Market Forecast, by Product Type 14.9.1. Acne and Rosacea Drugs 14.9.2. Fungal Infection Drugs 14.9.3. Psoriasis Drugs 14.9.4. Hyperpigmentation/ Melisma Drugs 14.9.5. Skin Cancer Drugs 14.9.6. Hair Loss and Hair Removal Drugs 14.9.7. Antiaging and Photo Damage Drugs 14.9.8. Dermatitis and Seborrhea Drugs 14.10. Brazil Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 14.10.1. Hospital Pharmacies 14.10.2. Retail pharmacies 14.10.3. Mail order pharmacies 14.11. Mexico Prescription Dermatology Therapeutics Market Forecast, by Product Type 14.11.1. Acne and Rosacea Drugs 14.11.2. Fungal Infection Drugs 14.11.3. Psoriasis Drugs 14.11.4. Hyperpigmentation/ Melisma Drugs 14.11.5. Skin Cancer Drugs 14.11.6. Hair Loss and Hair Removal Drugs 14.11.7. Antiaging and Photo Damage Drugs 14.11.8. Dermatitis and Seborrhea Drugs 14.12. Mexico Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 14.12.1. Hospital Pharmacies 14.12.2. Retail pharmacies 14.12.3. Mail order pharmacies 14.13. Rest of South America Prescription Dermatology Therapeutics Market Forecast, by Product Type 14.13.1. Acne and Rosacea Drugs 14.13.2. Fungal Infection Drugs 14.13.3. Psoriasis Drugs 14.13.4. Hyperpigmentation/ Melisma Drugs 14.13.5. Skin Cancer Drugs 14.13.6. Hair Loss and Hair Removal Drugs 14.13.7. Antiaging and Photo Damage Drugs 14.13.8. Dermatitis and Seborrhea Drugs 14.14. Rest of South America Prescription Dermatology Therapeutics Market Forecast, by Distribution Channel 14.14.1. Hospital Pharmacies 14.14.2. Retail pharmacies 14.14.3. Mail order pharmacies 14.15. South America Prescription Dermatology Therapeutics Market Attractiveness Analysis 14.15.1. By Product Type 14.15.2. By Distribution Channel 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. AbbVie, Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Janssen Biotech, Inc. 15.3.3. Novartis AG, Amgen, Inc. 15.3.4. Celgene Corporation 15.3.5. Pfizer, Inc. 15.3.6. LEO Pharma A/S 15.3.7. Eli Lilly and Company 15.3.8. Bausch Health Companies, Inc. 15.3.9. Sun Pharmaceuticals Ltd. 15.3.10. Aclaris Therapeutics, Inc. 15.3.11. Aurobindo Pharma Ltd. 15.3.12. Allergan Inc. 15.3.13. Bayer AG 15.3.14. Bristol-Myers Squibb Company 15.3.15. F. Hoffmann-La Roche Ltd. 15.3.16. Genentech, Inc. 15.3.17. GlaxoSmithKline Plc 15.3.18. Merck & Company, Inc. 15.3.19. SkinMedica 15.3.20. Stiefel Laboratories, Inc. 15.3.21. Valeant Pharmaceuticals, Inc. 15.3.22. Amgen, Inc. 16. Primary Key Insights